Quasi-experimental study of sodium citrate locks and the risk of acute hemodialysis catheter infection among critically ill patients

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 10, 2014, Pages 5666-5672

  Parienti, Jean Jacques ^a,b   Deryckère, Stéphanie ^a   Mégarbane, Bruno ^c   Valette, Xavier ^a   Seguin, Amélie ^a   Sauneuf, Bertrand ^a   Mira, Jean Paul ^d   Souweine, Bertrand ^e   Cattoir, Vincent ^a   Daubin, Cédric ^a   Cheyron, Damien Du ^a,b  

^a CHU CÔTE DE NACRE   (France)

^b UNIVERSITÉ DE CAEN   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d Cochin University Hospital Center ^*  (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CITRATE SODIUM; HEPARIN; CITRIC ACID;

AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COLONIZATION; CATHETER CARE; CATHETER COMPLICATION; CATHETER DYSFUNCTION; CATHETER INFECTION; CATHETER REMOVAL; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DIALYSIS CATHETER; DISINFECTION; FEMALE; FOLLOW UP; FUNGAL COLONIZATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE QUALITY; HEMODIALYSIS; HUMAN; HYPERTENSION; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; QUASI EXPERIMENTAL STUDY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; VEIN CATHETERIZATION; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CONFIDENCE INTERVAL; CRITICAL ILLNESS; MIDDLE AGED; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY;

AGED; CATHETER-RELATED INFECTIONS; CITRATES; CONFIDENCE INTERVALS; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 84907264334     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03079-14     Document Type: Article

References (39)

1. Hoste EAJ, Blot SI, Lameire NH, Vanholder RC, De Bacquer D, Colardyn FA. 2004. Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J. Am. Soc. Nephrol. 15:454-462. http://dx.doi.org /10.1097/01.ASN.0000110182.1460S.0C.
2. Parienti J-J, Dugué AE, Daurel C, Mira J-P, Mégarbane B, Mermel LA, Daubin C, du Cheyron D, Members of the Cathedia Study Group. 2010. Continuous renal replacement therapy may increase the risk of catheter infection. Clin. J. Am. Soc. Nephrol. 5:1489-1496. http://dx.doi.org /10,2215/CJN.02130310.
3. Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE. 2009. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit. Care Med. 37:2283-2289. http://dx.doi.org/30.3097/CCM.0b013e3181a02a67.
4. Schwebel C, Lucet J-C, Yesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit J-F. 2012. Economic evaluation of chlorhexidine -impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit. Care Med. 40:11-17. http://dx. doi.org,10.1097/CCM.0b013e31822f0604.
5. Hermite L, Quenot J-P, Nadji A, Barbar SD, Charles P-E, Hamet M, Jacquiot N, Ghiringhelli F, Freysz M. 2012. Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial. Intensive Care Med. 38:279-285. http://dx.doi.org/10.1007/s00134-011-2422-y.
6. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332. http://dx.doi.org/10.1016/j.ajic.2008.03.002.
7. Parienti J-J, Thirion M, Mégarbane B, Souweine B, Ouchikhe A, Polito A, Forel J-M, Marqué S, Misset B, Airapetian N, Daurel C, Mira J-P, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P, Members of the Cathedia Study Group. 2008. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299:2413-2422. http://dx.doi.org/30.3003/jama.299.20.2413.
8. Skofic N, Buturovic-Ponikvar J, Kovac J, Premru V, Knap B, Marn Pernat A, Kersnic B, Gubensek J, Ponikvar R. 2009. Hemodialysis catheters with citrate locking in critically ill patients with acute kidney injury treated with intermittent online hemofiltration or hemodialysis. Ther. Apher. Dial. 13:327-333. http://dx.doi.org/10.1111/j.1744-9987 .2009.00734.x.
9. Mrozek N, Lautrette A, Timsit J-F, Souweine B. 2012. How to deal with dialysis catheters in the ICU setting. Ann. Intensive Care 2:48. http://dx. doi.org/10.1186/2110-5820-2-48.
10. Dugué AE, Levesque SP, Fischer M-O, Souweine B, Mira J-P, Megarbane B, Daubin C, du Cheyron D, Parienti J-J, Cathedia Study Group. 2012. Vascular access sites for acute renal replacement in intensive care units. Clin. J. Am. Soc. Nephrol. 7:70-77. http://dx.doi.org/10.2215/CJN .06570711.
11. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee. 2011. Guidelines for the prevention of intravascular catheter-related infections. Am. J. Infect. Control 39(Suppl 1):S1-S34. http://dx. doi.org/30.3036/j.ajic.2011.03.003.
12. Parienti J-J, du Cheyron D, Ramakers M, Malbruny B, Leclercq R, Le Coutour X, Charbonneau P, Members of the NACRE Study Group. 2004. Alcoholic povidone-iodine to prevent central venous catheter colonization: arandomized unit-crossover study. Crit. Care Med. 32:708-713. http://dx.doi.org/10.1097/01.CCM.0000115265.05604.7B.
13. Parienti J-J, Mégarbane B, Fischer M-O, Lautrette A, Gazui N, Marin N, Hanouz J-L, Ramakers M, Daubin C, Mira J-P, Charbonneau P, du Cheyron D, Cathedia Study Group. 2010. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit. Care Med. 38:1118-1125. http://dx.doi.org/10.1097/CCM.0b013e3181d454b3.
14. Raad I, Bodey GP, Sr. 2011. Novel antimicrobial catheter lock solution: a new direction in which chelators replace heparin. Crit. Care Med. 39:875-876. http://dx.doi.org/10.1097/CCM.0b033e31820e4474.
15. Souweine B, Traore O, Aublet-Cuvelier B, Badrikian L, Bret L, Sirot J, Gazuy N, Laveran H, Deteix P. 1999. Dialysis and central venous catheter infections in critically ill patients: results of a prospective study. Crit. Care Med. 27:2394-2398. http://dx.doi.org/10.1097/00003246-199911000-00012.
16. Wester JPJ, de Koning EJP, Geers ABM, Vincent HH, de Jongh BM, Tersmette M, Leusink JA, Analysis of Renal Replacement Therapy in the Seriously Ill (ARTIS) Investigators. 2002. Catheter replacement in continuous arteriovenous hemodiafiltration: the balance between infectious and mechanical complications. Crit. Care Med. 30:1261-1266. http: //dx.doi.org/10.1097/00003246-200206000-00017.
17. Souweine B, Liotier J, Heng AE, Isnard M, Ackoundou-N'Guessan C, Deteix P, Traoré O. 2006. Catheter colonization in acute renal failure patients: comparison of central venous and dialysis catheters. Am. J. Kidney Dis. 47:879-887. http://dx.doi.org/10.1053/j.ajkd.2006.01.023.
18. Klouche K, Amigues L, Deleuze S, Beraud J-J, Canaud B. 2007. Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure. Am. J. Kidney Dis. 49:99-108. http: //dx.doi.org/10.1053/j.ajkd.2006.09.014.
19. Mermel LA. 2011. What is the predominant source of intravascular catheter infections? Clin. Infect. Dis. 52:211-212. http://dx.doi.org/30.3093 /cid/ciq108.
20. Fux CA, Uehlinger D, Bodmer T, Droz S, Zellweger C, Mühlemann K. 2005. Dynamics of hemodialysis catheter colonization by coagulase -negative staphylococci. Infect. Control Hosp. Epidemiol. 26:567-574. http://dx.doi.org/10.1086/502586.
21. Mermel LA. 8 January 2014. What is the evidence for intraluminal colonization of hemodialysis catheters? Kidney Int. http://dx.doi.org/10.1038 /ki.2033.527.
22. Shanks RMQ, Sargent JL, Martinez RM, Graber ML, O'Toole GA. 2006. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol. Dial. Transplant. 21:2247-2255. http://dx.doi.org/10.1093/ndt/gfl170.
23. Sungur M, Eryuksel E, Yavas S, Bihorac A, Layon AJ, Caruso L. 2007. Exit of catheter lock solutions from double lumen acute haemodialysis catheters-an in vitro study. Nephrol. Dial. Transplant. 22:3533-3537. http://dx.doi.org/10.1093/ndt/gfm452.
24. Schilcher G, Schneditz D, Ribitsch W, Horina JH, Hoenigl M, Valentin T, Rosenkranz AR, Krause R. 9 February 2014. Loss of antimicrobial effect of trisodium citrate due to "lock" spillage from haemodialysis catheters. Nephrol. Dial. Transplant, http://dx.doi.org/10.1093/ndt/gft527.
25. Bleyer AJ. 2007. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin. J. Am. Soc. Nephrol. 2:1073-1078. http: //dx.doi.org/10.2215/CJN.00290107.
26. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. 2008. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis. 47:83-93. http://dx.doi.org/10.1086/588667.
27. Landry DL, Braden GL, Gobeille SL, Haessler SD, Vaidya CK, Sweet SJ. 2010. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin. J. Am. Soc. Nephrol. 5:1799-1804. http://dx.doi.org/10.2215/CJN.01270210.
28. Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C. 2009. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol. Dial. Transplant. 24:3204-3209. http://dx.doi.org/10.1093/ndt/gfp187.
29. Schilcher G, Schlagenhauf A, Schneditz D, Scharnagl H, Ribitsch W, Krause R, Rosenkranz AR, Stojakovic T, Horina JH. 2013. Ethanol causes protein precipitation-new safety issues for catheter locking techniques. PLoS One 8:e84869. http://dx.doi.org/10.1371/journal.pone .0084869.
30. Slobbe L, Doorduijn JK, Lugtenburg PJ, El Barzouhi A, Boersma E, van Leeuwen WB, Rijnders BJA. 2010. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One 5:e10840. http://dx.doi. org/10.1371/joumal.pone.0010840.
31. Zhao Y, Li Z, Zhang L, Yang J, Yang Y, Tang Y, Fu P. 11 October 2013. Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am. J. Kidney Dis. http://dx.doi.org/10.1053/j.ajkd.2013.08.016.
32. Maki DG, Ash SR, Winger RK, Lavin P, AZEPTIC Trial Investigators. 2011. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit. Care Med. 39:613-620. http://dx.doi.org/10.1097/CCM.0b013e318206b5a2.
33. Rosenblatt J, Reitzel R, Dvorak T, Jiang Y, Hachem RY, Raad II. 2013. Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob. Agents Chemother. 57:3555-3560. http://dx.doi.org/10 .1128/AAC.00229-13.
34. Winnett G, Nolan J, Miller M, Ashman N. 2008. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol. Dial. Transplant. 23:3592-3598. http://dx.doi.org/10 .1093/ndt/gfn299.
35. Weijmer MC, van den Dorpel MA, Van de Ven PJG, ter Wee PM, van Geelen JACA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CEH, Stas KJF, CITRATE Study Group. 2005. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol. 16:2769-2777. http://dx.doi.org/10 .1681/ASN.2004100870.
36. Timsit JE, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, Carlet J. 1998. Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 114:207-213. http://dx.doi.org/10.1378/chest.114.1.207.
37. Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM. 2002. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol. Dial. Transplant. 17:2189-2195. http: //dx.doi.org/10.1093/ndt/17.12.2189.
38. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, Sexton B, Hyzy R, Welsh R, Roth G, Bander J, Kepros J, Goeschel C. 2006. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355:2725-2732. http://dx.doi.org/10.1056 /NEJMoa061115.
39. Timsit J-F, Bouadma L, Mimoz O, Parienti J-J, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault M-C, Schwebel C, Ruckly S, Souweine B, Lucet J-C. 2013. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials. Am. J. Respir. Crit. Care Med. 188:1232-1239. http: //dx.doi.org/10.1164/rccm.201303-04600C.